Author:
Linares Rodolfo López,Benítez Jonnathan Guadalupe Santillán,Reynoso Mariana Ortiz,Romero Carlos González,Sandoval-Cabrera Antonio
Abstract
AbstractOne of the factors that has increased the incidence and worse prognosis of breast cancer is obesity. In this condition, high amounts of leptin are secreted, which have proliferative, mitogenic, antiapoptotic, and proinflammatory activity that may be antagonistic to treatment with tamoxifen, considered the first choice. The modulation evaluation of leptin receptor expression in the presence of leptin and tamoxifen stimuli was performed in breast cancer cell lines MCF 7, MDA MB 231 and HCC 1937 as a model of initial approach for the study of breast cancer subtypes and their behavior to the action response of adipokines and their possible relationship with the mechanism of resistance to chemotherapeutics such as tamoxifen in ER positive cell lines and triple negative marker. It was determined that leptin increases the proliferation of the three breast cancer cell lines and tamoxifen is able to exert an antiproliferative effect on them, however, it was identified that the ability of tamoxifen to decrease the proliferation of cancer cells is diminished in the presence of leptin, in addition to changes in the modulation of the expression of its receptor. It was determined that tamoxifen induces a greater modulation of the expression of ObRb in cell lines, which may be related to the decrease of its antiproliferative activity, while leptin generates a proliferative effect in the three cell lines and could participate in the tamoxifen treatment resistance mechanism.
Funder
Universidad AutÓnoma del Estado de México
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Uusitalo, E. et al. Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors. British Journal of Cancer. 116(2), 211–217 (2016).
2. Santillán-Benítez, J., Quiroz-Ordoñes, Á., Mendieta-Zerón, H. & Gómez-Oliván, L. Expresión génica y receptores hormonales en cáncer mamario. “El camino hacia la búsqueda de terapias preventivas” Revista de Medicina e investigación 1(1), 17–24 (2013).
3. Casanello, P., Krause, B., Castro-Rodríguez, J. & Uauy, R. Epigenética y obesidad. Rev Chil Pediatr. 87(5), 335–342 (2016).
4. Simone, V. et al. Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications. The Oncologist. 21(4), 404–417 (2016).
5. San Román, G. Obesidad y cáncer. Revista de Gastroenterología de México. 81(Supl 1), 1–3 (2016).
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献